| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 |
| Total Expenses - EUR | - | 725 | 5.994 | 673 | 322 | 321 | 340 | 371 | 334 | 812 |
| Gross Profit/Loss - EUR | - | -708 | -5.994 | -673 | -322 | -321 | -340 | -371 | -330 | -812 |
| Net Profit/Loss - EUR | - | -708 | -5.994 | -673 | -322 | -321 | -340 | -371 | -330 | -812 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Camadria Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 292 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.966 | 3.477 | 3.266 | 3.199 | 3.132 | 3.127 | 1.051 | 1.048 | 1.054 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 3.966 | 3.477 | 3.266 | 3.199 | 3.132 | 3.127 | 1.051 | 1.048 | 1.054 |
| Shareholders Funds | - | -664 | 3.161 | 2.430 | 2.061 | 1.701 | 1.323 | 956 | 623 | -192 |
| Social Capital | - | 45 | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | - | 4.922 | 315 | 836 | 1.139 | 1.431 | 1.804 | 95 | 425 | 1.246 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Camadria Medical S.r.l.